The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Tirzepatide in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a novel star on the horizon?”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Amedeo Lonardo, Ralf Weiskirchen. Drug treatment of MASH from none to (too) many options?, Exploration of Medicine. 2025; 6: 1001378. https://doi.org/10.37349/emed.2025.1001378 |
|
2 |
2026 |
Min Hyeok Shin, Jin Woo Jeong, Se Eun Ha, Rajan Singh, Moon Young Lee, Seungil Ro, Tae Yang Yu. Multidimensional Predictors of Tirzepatide Efficacy: Clinical, Genetic, and Molecular Biomarkers for Glycemic, Weight, and Organ Protection, Pharmaceuticals. 2026; 19: 791. https://doi.org/10.3390/ph19050791 |
|
3 |
2025 |
Amedeo Lonardo, Ralf Weiskirchen. Insulin Resistance at the Crossroads of Metabolic Inflammation, Cardiovascular Disease, Organ Failure and Cancer, Biomolecules. 2025; 15: 1745. https://doi.org/10.3390/biom15121745 |
|
4 |
2026 |
Irshad Khan, Sarasa Meenakshi, Md. Abubakar, Nitesh Kumar, Vinod L Gaikwad, Amita Rai, Krishna Murti. Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation, Endocrine. 2026; 91: 216. https://doi.org/10.1007/s12020-026-04686-5 |